Ming Yan, Chief Technology Officer at Cytek Biosciences, Inc. (CTKB), sold 1,092 shares at $13.51 ($15K) on 2023-02-03, disclosed to the SEC on 2023-02-07.
Scheduled sale ($15k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 1,081 | $15K | 99.0% |
| 2 | $13.51 | 11 | $149 | 1.0% |
| Total | $13.50 avg | 1,092 | $15K | 100% |
| Filing → |
| CTKB | SELL | 2024-03-19 | $270K | — | Filing → |
| CTKB | SELL | 2023-12-21 | $189K | — | Filing → |
| CTKB | SELL | 2023-11-21 | $121K | — | Filing → |